Meet the Team

The Glo-BNHL trial is co-ordinated by the Children’s Cancer Trials Team (CCTT) based within the Cancer Research Clinical Trials Unit (CRCTU) at the University 麻豆精选.

 

Professor Amos Burke

Professor Amos Burke, Chief Investigator

Professor Lucinda Billingham

Professor Lucinda Billingham, Chief Biostatistician

Emma Seaford

Dr Emma Seaford Lead, Early Career Investigator

Anna Lawson_HeadshotAnna Lawson, Trial Management Team Leader
Rebecca BishopRebecca Bishop, Industry Trials Hub Lead
Ellie Williams_HeadshotEllie Williams, Senior Trial Coordinator
Joe Rogers_HeadshotJoseph Rogers, Senior Trial Coordinator 

Rhi Parsons_Headshot2Rhianna Parsons, Project Manager

Shanna Maycock_Headshot

Shanna Maycock, Senior Biostatistician

Jiayi Wang_Headshot

Jiayi Wang, Trial Statistician

Mahnoor

Mahnoor Muzaffar, Trial Coordinator

Zahra Ahmed_HeadshotZahra Ahmed, Trial Coordinator
Akshay Deshpande_HeadshotDr Akshay Deshpande, Clinical Research Fellow

 

Treatment Arm Investigators

Treatment Arm Lead Investigators contribute to the Glo-BNHL trial by acting as deputies for the Chief Investigator’s for a specific treatment arm of the trial. There are two Lead Investigators for each arm, and two Early Career Investigators in each arm support them.

  • Sarah Alexander
    Treatment Arm I Co-lead
  • Simon Bomken
    Treatment Arm I Co-lead
  • Charles Phillips
    Treatment Arm I Early Career Investigator
  • Charlotte Rigaud
    Treatment Arm I Early Career Investigator
  • Birte Wistinghausen
    Treatment Arm II Co-lead
  • Auke Beishuizen
    Treatment Arm II Co-lead
  • Emma Seaford
    Treatment Arm II Early Career Investigator
  • James Ford
    Treatment Arm II Early Career Investigator
  • Véronique Minard
    Treatment Arm III Co-lead
  • Joerg Kruger
    Treatment Arm III Co-lead
  • Keri Toner
    Treatmement Arm III Early Career Investigator
  • Friederike Meyer-Wentrup
    Treatment Arm III Early Career Investigator

Trial Management Group

The Trial Management Group (TMG) is a group of professionals from many different fields and organisations. The TMG meets several times a year to assist with the overall management of the trial and to make important trial related decisions.

  • Amos Burke (Chief Investigator, CRCTU)
  • Lucinda Billingham (Chief Biostatistician, CRCTU)
  • Anna Lawson (Trial Management, CRCTU)
  • Ellie Williams (Trial Management, CRCTU)
  • Joe Rogers (Trial Management, CRCTU)
  • Mahnoor Muzaffar (Trial Management, CRCTU)
  • Zahra Ahmed (Trial Management, CRCTU)
  • Shanna Maycock (Senior Biostatistician, CRCTU)
  • Jiayi Wang (Statistician, CRCTU)
  • Nicole Scobie (European Consumer Representative)
  • Dave Hulme (European Consumer Representative)
  • Angela Lee (US Consumer Representative)
  • Suzanne Turner (Biology Lead, UK Academic)
  • Sarah Alexander (Treatment Arm I Co-lead, Canadian Academic)
  • Simon Bomken (Treatment Arm I Co-lead, European Academic)
  • Auke Beishuizen (Treatment Arm II Co-lead, European Academic)
  • Birte Wistinghausen (Treatment Arm II Co-lead, US Academic)
  • Véronique Minard (Treatment Arm III Co-lead, European Academic)
  • Joerg Kruger (Treatment Arm III Co-lead, US Academic)
  • Charlotte Rigaud (Treatment Arm I Early Career Investigator, European Academic)
  • Charles Phillips (Treatment Arm I Early Career Investigator, US Academic)
  • Emma Seaford (Treatment Arm II Early Career Investigator, UK Academic)
  • James Ford (Treatment Arm II Early Career Investigator, US Academic)
  • Friederike Meyer-Wenthrup (Treatment Arm III Early Career Investigator, European Academic)
  • Keri Toner (Treatment Arm III Early Career Investigator, US Academic)
  • Representatives from each NCC (TBC)
  • Sub-study Leads (TBC)

Trial Steering Committee

The international Trial Steering Committee (TSC) is a group of independent professionals, whose role is to provide overall supervision for the trial on behalf of the Trial Sponsor (University 麻豆精选) and the Trial Funders (Cancer Research UK and Fight Kids Cancer). They make sure that the trial is performed in line with the high standards of International Conference on Harmonisation Good Clinical Practice (ICH-GCP), most importantly focusing on the safety and well-being of the children, adolescents and young people involved.

  • Lia Gore (Independent Chair, Clinician, US Academic)
  • Amos Burke (Chief Investigator, CRCTU)
  • Emma Seaford (Clinician, European Academic)
  • Sarah Alexander (Clinician, Canadian Academic)
  • Carl Allen (Clinician, US Academic)
  • Auke Beishuizen (Clinician, European Academic)
  • Lucinda Billingham (Statistician, CRCTU)
  • Shanna Maycock (Statistician, CRCTU)
  • Anne Auperin (Statistician, European Academic)
  • Catherine Bollard (Clinician, US Academic)
  • Victoria Buenger (US Consumer Representative)
  • Willemijn Plieger-van Solkema (European Consumer Representative)
  • Véronique Minard (Clinician, European Academic)
  • Birte Wistinghausen (Clinician, US Academic)
  • Anna Lawson (Trial Management, CRCTU)
  • Ellie Williams (Trial Management, CRCTU)
  • Joe Rogers (Trial Management, CRCTU)
  • Zahra Ahmed (Trial Management, CRCTU)
  • Mahnoor Muzaffar (Trial Management, CRCTU)